Accelerated hypofractionated radiotherapy in men with localized prostate cancer: long-term outcomes

被引:0
|
作者
Galalae, R
Schultze, J
Nuernberg, N
Kohr, P
机构
[1] Univ Hosp Schleswig Holstein, Kiel, Germany
[2] Municipal Hosp, Kiel, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S403 / S403
页数:1
相关论文
共 50 条
  • [31] Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 Weeks
    Nakamura, Kiyonao
    Ikeda, Itaru
    Inokuchi, Haruo
    Aizawa, Rihito
    Ogata, Takashi
    Akamatsu, Shusuke
    Kobayashi, Takashi
    Mizowaki, Takashi
    PRACTICAL RADIATION ONCOLOGY, 2023, 13 (06) : E530 - E537
  • [32] Hypofractionated intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcome results
    Thakkar, VV
    Khuntia, D
    Reddy, CA
    Mahadevan, EA
    Klein, A
    Chehade, N
    Kupelian, PA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S124 - S125
  • [33] Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer
    Teh, Bin S.
    Lewis, Gary D.
    Mai, Weiyuan
    Pino, Ramiro
    Ishiyama, Hiromichi
    Butler, Edward Brian
    CANCER COMMUNICATIONS, 2018, 38
  • [34] Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes
    Faria, Sergio L.
    Neto, Osmar B.
    Cury, Fabio
    Shenouda, George
    Russel, Ruo
    Souhami, Luis
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (02) : 8209 - 8214
  • [35] Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
    Koukourakis, Ioannis M.
    Panteliadou, Marianthi
    Giakzidis, Axiotis G.
    Nanos, Christos
    Abatzoglou, Ioannis
    Giatromanolaki, Alexandra
    Koukourakis, Michael I.
    CURRENT ONCOLOGY, 2021, 28 (05) : 3474 - 3487
  • [36] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
    Morgan, Scott C.
    Holmes, Oliver E.
    Craig, Julia
    Grimes, Scott
    Malone, Shawn
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 1041 - 1047
  • [37] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
    Scott C. Morgan
    Oliver E. Holmes
    Julia Craig
    Scott Grimes
    Shawn Malone
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 1041 - 1047
  • [38] Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/fraction).
    Mian, Omar Y.
    Abu-Gheida, Ibrahim
    Kotecha, Rupesh
    Weller, Michael A.
    Reddy, Chandana A.
    Kupelian, Patrick
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    Stephenson, Andrew J.
    Klein, Eric A.
    Shah, Chirag
    Ciezki, Jay P.
    Stephans, Kevin L.
    Tendulkar, Rahul D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [39] Long-Term Outcomes Of Hypofractionated Stereotactic Radiotherapy For Treatment Of Arteriovenous Malformation
    Glazener, E. M.
    Chen, J. C. T.
    Lodin, K.
    Miller, M. J.
    Rahimian, J.
    Frager, M. J.
    Girvigian, M. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E726 - E726
  • [40] Long-term outcomes in patients treated with proton therapy for localized prostate cancer
    Takagi, Masaru
    Demizu, Yusuke
    Terashima, Kazuki
    Fujii, Osamu
    Jin, Dongcun
    Niwa, Yasue
    Daimon, Takashi
    Murakami, Masao
    Fuwa, Nobukazu
    Okimoto, Tomoaki
    CANCER MEDICINE, 2017, 6 (10): : 2234 - 2243